Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas

JAMA

Volumn 278, Issue 1, 1997, Pages 40-43

  Shorr, Ronald I ^a,b   Ray, Wayne A ^c   Daugherty, James R ^c   Griffin, Marie R ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Methodist Hospitals of Memphis   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; THIAZIDE DIURETIC AGENT;

AGED; AGING; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SAFETY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030920542     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.1.40     Document Type: Article

References (25)

1. Harris MI. Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med. 1990;6:703-719.
2. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993; 153:154-183.
3. Arauz-Pacheco C, Ramirez LC, Rios JM, Raskin P. Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy. Am J Med. 1990;89:811-813.
4. Rett K, Wicklmayr M, Dietze GJ. Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril. N Engl J Med. 1988;319:1609.
5. Herings RM, de Boer A, Stricker BH, Leufkens HG, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin-converting enzyme. Lancet. 1995;345:1195-1198.
6. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993;118:129-138.
7. Tse WY, Kendall M. Is there a role for beta-blockers in hypertensive diabetic patients? Diabet Med. 1994;11:137-144.
8. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
9. Payne CD. Generalized Linear Interactive Modelling Manual: The GLIM System, Release 3.77. Oxford, England: Royal Statistical Society; 1987.
10. Barnett AH, Leslie D, Watkins PJ. Can insulin-treated diabetics be given beta-adrenergic blocking drugs? BMJ. 1980;280:976-978.
11. The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus: final report. Arch Intern Med. 1987;147:830-842.
12. Treatment of hypertension in diabetes. Diabetes Care. 1993;16:1394-1401.
13. Deacon SP, Karunanayake A, Barnett D. Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. BMJ. 1977;2:1255-1257.
14. Kerr D, MacDonald IA, Heller SK, Tattersall RB. Beta-adrenoceptor blockade and hypoglycaemia: a randomised, double-blind placebo-controlled comparison of metoprolol CR, atenolol, and propranolol LA in normal subjects. Br J Clin Pharmacol 1990;29:685-693.
15. Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM. Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med. 1990;7:711-717.
16. Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR. Unawareness of hypoglycaemia and inadequate hypoglyeaemic counterregulation: no causal relation with diabetic autonomie neuropathy. BMJ. 1990;301:783-787.
17. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801-807.
18. Kjekshus J, Gilpin E, Cali G, Blackey AR, Henning H, Ross J Jr. Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J. 1990;11:43-50.
19. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA. 1982;247:1707-1714.
20. Australian and Swedish Pindolol Study Group. The effect of pindolol on the two years mortality after complicated myocardial infarction. Eur Heart J. 1983;4:367-375.
21. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Heart J. 1985;6:199-226.
22. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2: 57-66.
23. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet. 1981;2:823-827.
24. Wallin JD, Shah SV. Beta-adrenergic blocking agents in the treatment of hypertension: choices based on pharmacological properties and patient characteristics. Arch Intern Med. 1987;147:654-659.
25. Fatourechi V, Kennedy FP, Rizza RA, Hogan MJ. A practical guideline for management of hypertension in patients with diabetes. Mayo Clin Proc. 1996;71:53-58.